معرفی
Janet L. Abrahm, MD, is a Professor of Medicine at Harvard Medical School and an Institute Physician at the Dana-Farber Cancer Institute (DFCI), where she practices palliative care at Brigham and Women’s Hospital (BWH). She has played a transformative role in advancing palliative and supportive oncology through clinical innovation, education, and national leadership.
- Harvard Medical School – Professor of Medicine
- Dana-Farber Cancer Institute – Institute Physician, Adult Palliative Care
- Brigham and Women’s Hospital – Palliative Care Practitioner
- Psychosocial Oncology and Palliative Care Department – Research Leadership
Dr. Abrahm completed her medical training at the University of California, San Francisco (UCSF), residency at Massachusetts General Hospital, chief residency at Moffitt Hospital (UCSF), and fellowships in hematology and oncology at the Hospital of the University of Pennsylvania.
- Medical Degree: University of California, San Francisco
- Residency: Massachusetts General Hospital, Medicine
- Chief Resident: Moffitt Hospital, UCSF
- Fellowship: Hospital of the University of Pennsylvania, Hematology/Oncology and Quality Management
- Board Certified: Internal Medicine, Hematology, Oncology, Hospice and Palliative Medicine
Her research and clinical interests center on integrating palliative care into oncology practice through evidence-based symptom management, clinical decision support (CDS), and health informatics. She specializes in metastatic spinal cord compression, interpreter and clergy collaboration in palliative care, and algorithm-driven patient-specific treatment recommendations. Her work leverages national guidelines to embed primary palliative care into electronic health records, enhancing oncologists’ ability to manage cancer-related suffering.
Dr. Abrahm’s extensive publication record includes over 150 works, highlighted by the 4th edition of her seminal book, Comprehensive Guide to Supportive and Palliative Care for Patients with Cancer. Her recent research focuses on developing and implementing CDS algorithms for the nine most common cancer symptoms, funded by NIH SBIR grants. This work bridges palliative care with oncology through scalable, technology-driven solutions.
She has received numerous accolades recognizing her leadership and educational impact:
- Walther Cancer Foundation Supportive Oncology Award, ASCO (2024)
- AAHPM Award for Excellence in Education and Training (2022)
- UCSF Alumni Discovery Award (2022)
- Edward J. Benz, Jr. Award for Advancing Careers of Women Faculty, DFCI (2019)
Dr. Abrahm has held major administrative and educational roles, including leadership in the American Academy of Hospice and Palliative Medicine (AAHPM), membership in ASCO’s international palliative care faculty, and participation in the Education in Palliative and End-of-Life (EPEC)-Oncology course as a master teacher. She was instrumental in creating the first palliative care service and fellowship at DFCI and BWH in 2001, after two decades as a hematologist/oncologist. She has mentored countless professionals and contributed to national palliative care curriculum development.
Her research is conducted within the Psychosocial Oncology and Palliative Care department at DFCI, where she leads a team focused on clinical decision support systems. The group is currently preparing a Phase 2 NIH SBIR implementation grant to expand their algorithm-based symptom management tools into broader clinical practice.
